Literature DB >> 28504575

Alleviation of enterotoxigenic Escherichia coli challenge by recombinant Lactobacillus plantarum expressing a FaeG- and DC-targeting peptide fusion protein.

G Yang1, Y Jiang1, P Tong2, C Li1, W Yang1, J Hu1, L Ye1, W Gu3, C Shi1, B Shan3, C Wang1.   

Abstract

FaeG is the major subunit of K88 fimbriae. These cell surface attachments are considered to be the major virulence factor of enterotoxigenic Escherichia coli (ETEC), which causes diarrhoea in piglets. The use of dendritic cell-targeting peptide (DCpep) has been demonstrated to be an effective approach to enhance the immunity of vaccines. Lactobacillus plantarum is an attractive candidate for oral vaccination owing to its beneficial effects and safety. In this study, L. plantarum was employed to deliver a FaeG-DCpep fusion antigen, and the immune response in mice was evaluated. The synthesis of FaeG-DCpep dramatically increased the adhesion of recombinant L. plantarum (RLP) to IPEC-J2 cell surfaces, resulting in direct competition between L. plantarum and ETEC during adhesion assays. Significantly higher levels of body weight gain, sera immunoglobulin G and intestinal immunoglobulin A were observed in BALB/c mice immunised with RLP. In addition, the number of CD19+ B cells and CD11c+DC cells and the expression levels of several cytokines in the spleen and lymph nodes increased significantly compared to non-immunised mice. The oral administration of RLP also alleviated the symptoms of ETEC challenge, as shown by haematoxylin-eosin staining, indicating that RLP may be an efficient vaccine candidate.

Entities:  

Keywords:  DC-targeting peptide; ETEC; FaeG; Lactobacilus plantarum; immune response

Mesh:

Substances:

Year:  2017        PMID: 28504575     DOI: 10.3920/BM2016.0116

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  9 in total

Review 1.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

2.  Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.

Authors:  Xiaohong Xu; Jing Qian; Lingsong Qin; Jindou Li; Cong Xue; Jiaxin Ding; Weiqi Wang; Wei Ding; Renfu Yin; Ningyi Jin; Zhuang Ding
Journal:  Virol Sin       Date:  2020-04-09       Impact factor: 4.327

Review 3.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 4.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

5.  Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus.

Authors:  Sunting Ma; Li Wang; Xuewei Huang; Xiaona Wang; Su Chen; Wen Shi; Xinyuan Qiao; Yanping Jiang; Lijie Tang; Yigang Xu; Yijing Li
Journal:  Microb Cell Fact       Date:  2018-02-09       Impact factor: 5.328

6.  E. coli Enterotoxin LtB Enhances Vaccine-Induced Anti-H. pylori Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions.

Authors:  Xiaoyan Peng; Rongguang Zhang; Chen Wang; Feiyan Yu; Mingyang Yu; Shuaiyin Chen; Qingtang Fan; Yuanlin Xi; Guangcai Duan
Journal:  Cells       Date:  2019-08-27       Impact factor: 6.600

7.  Construction and immunogenicity analysis of Lactobacillus plantarum expressing a porcine epidemic diarrhea virus S gene fused to a DC-targeting peptide.

Authors:  Ke-Yan Huang; Gui-Lian Yang; Yu-Bei Jin; Jing Liu; Hong-Liang Chen; Peng-Bo Wang; Yan-Long Jiang; Chun-Wei Shi; Hai-Bin Huang; Jian-Zhong Wang; Guan Wang; Yuan-Huan Kang; Wen-Tao Yang; Chun-Feng Wang
Journal:  Virus Res       Date:  2017-12-27       Impact factor: 3.303

Review 8.  Lactobacillus Mucosal Vaccine Vectors: Immune Responses against Bacterial and Viral Antigens.

Authors:  Jonathan S LeCureux; Gregg A Dean
Journal:  mSphere       Date:  2018-05-16       Impact factor: 4.389

Review 9.  Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines.

Authors:  Allison C Vilander; Gregg A Dean
Journal:  Vaccines (Basel)       Date:  2019-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.